Dr. Larrick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1230 Bordeaux Dr
Sunnyvale, CA 94089Phone+1 415-263-6311
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Radiology-Diagnostic, 1981 - 1981- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1980 - 1981
Duke University School of MedicineClass of 1980
Certifications & Licensure
CA State Medical License 1981 - 2027
Publications & Presentations
PubMed
- Seroprevalence of West Nile Fever and Associated Risk Factors in Livestock of Afar Region, Northeast Ethiopia.Jemberu Alemu Megenas, Mengistu Legesse Dadi, Tesfu Kassa Mekonnen, James W Larrick, Gezahegne Mamo Kassa
Veterinary Sciences. 2025-02-08 - 1 citationsElectroencephalographic and Behavioral Effects of Intranasal Administration of a Na, K-ATPase-Activating Antibody after Status Epilepticus.Fernanda Kulinski Mello, Tuane Bazanella Sampaio, Bruna Neuberger, Michele Pereira Mallmann, Michele Rechia Fighera
ACS Chemical Neuroscience. 2024-08-07 - 1 citationsSeroprevalence and Co-Circulation of Rift Valley Fever Virus and West Nile Fever Virus in Livestock Population of Afar Region, Northeast Ethiopia.Jemberu Alemu Megenas, Mengistu Legesse Dadi, Tesfu Kassa Mekonnen, James W Larrick, Gezahegne Mamo Kassa
Veterinary Medicine International. 2024-01-01
Press Mentions
Electroencephalographic and Behavioral Effects of Intranasal Administration of a Na+, K+-ATPase-Activating Antibody After Status EpilepticusJuly 16th, 2024
Grant Support
- Novel therapy to prevent alveolar bone loss in severe periodontitisPANORAMA RESEARCH, INC.2024–2025
- Novel therapy to prevent alveolar bone loss in severe periodontitisPANORAMA RESEARCH, INC.2024–2025
- Novel therapy to prevent alveolar bone loss in severe periodontitisPANORAMA RESEARCH, INC.2024–2025
- Novel therapy to prevent alveolar bone loss in severe periodontitisPANORAMA RESEARCH, INC.2024–2025
- Novel therapy to prevent alveolar bone loss in severe periodontitisPANORAMA RESEARCH, INC.2024–2025
- Novel therapy to prevent alveolar bone loss in severe periodontitisPANORAMA RESEARCH, INC.2024–2025
- Novel therapy to prevent alveolar bone loss in severe periodontitisPANORAMA RESEARCH, INC.2024–2025
- Novel therapy to prevent alveolar bone loss in severe periodontitisPANORAMA RESEARCH, INC.2024–2025
- Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementiaPANORAMA RESEARCH, INC.2023–2025
- Silencing autoantibody secretion for SLE therapyLARIX BIOSCIENCE, LLC2023–2025
- Novel therapy for arthrofibrosisPANORAMA RESEARCH, INC.2023–2025
- Therapy for ectopic calcification in pseudoxanthoma elasticumLARIX BIOSCIENCE, LLC2023–2025
- Advancing a novel therapy for preeclampsiaLARIX BIOSCIENCE, LLC2022–2025
- Therapeutic antibody for hyperemesis gravidarumLARIX BIOSCIENCE, LLC2022–2025
- Therapeutic antibody for hyperemesis gravidarumLARIX BIOSCIENCE, LLC2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
